In the case of NRG1 overexpression, the binding rate of NRG1 to HER3 (k8on) was identified as a significant parameter that impacts tumor growth (Fig. 6a), indicating that this physiological process could be an important therapeutic target for NRG1-overexpressing tumors. The gene discussed is ERBB3; the disease is neoplasm.